Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
Go back to Oruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026| (NASDAQ: ORKA) | Delayed: 83.40 -1.98 (2.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.38 | 52 Week High | $ | |||
| Open | $84.01 | 52 Week Low | $ | |||
| Day High | $87.10 | P/E | N/A | |||
| Day Low | $83.07 | EPS | $ | |||
| Volume | 1,327,369 | |||||
